WHO backs antibody treatment for high-risk Covid patients. Here are other Covid19 updates: 🇧🇷 Brazil approaches 600,000 virus deaths 🇰🇷 South Korea reports record high daily cases of 2,434 🇦🇺 Melbourne cases linger near record levels For more:
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020. The World Health Organization recommended the synthetic antibody treatment Regeneron for the virus, but only in patients with specific health profiles.
Regeneron is only the third treatment for the virus to be recommended by the global health authority, which added it to its "living WHO guideline" on drugs for Covid-19.South Korea reported a new record high daily virus cases of 2,434, breaking the record set last month, as the country grapples with the worst-ever wave of infections since early July, the Korea Disease Control and Prevention Agency said.
Health Ministry officials have previously said the real coronavirus numbers are likely significantly higher.Brazil has had 24,611 new cases of the novel virus reported in the past 24 hours, and 648 deaths from the virus, the health ministry said. As vaccination advances, the rolling 7-day average of deaths has fallen to less than one fifth of the toll of almost 3,000 a day at the peak of the pandemic in April.Infections in Australia's Victoria state hovered near record levels as authorities stepped up the pace of vaccinations in hopes of easing restrictions with more than half the country's adult population fully vaccinated.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Read more »
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe FDA authorized Pfizer booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.
Read more »
FDA backs Pfizer COVID-19 boosters for seniors, high-riskThe U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19.
Read more »
Education Secretary backs mandatory school Covid-19 vaccinesEducation Secretary Miguel Cardona declared his support for mandatory Covid-19 vaccinations for eligible schoolchildren, saying the FDA’s approval of jabs for some adolescents should clear the way for state officials to begin vaccinations
Read more »
COVID-19 Causes Major Interruption in Global HIV ProgressFrom testing to treatment, Global Fund HIV services have been hampered by COVID-19. But U.S. providers shouldn't rest on their laurels either.
Read more »
Smaller COVID vaccine doses may protect children as well as full doses in adults: PfizerPfizer just released its first safety data about COVID-19 vaccines for children ages 5 to 11, reassuring parents that a safe and effective vaccine soon could be available for those younger than 12.
Read more »